Catalog Number : 1249980
Losartan potassium is a selective angiotensin II receptor type 1 (AT1) antagonist with antihypertensive properties. It is metabolized to produce the 5-carboxylic acid metabolite (EXP3174) and is reported to lower blood pressure. It is currently being researched as a potential treatment for COVID-19 for its potential to mitigate or possibly attenuate the symptoms of COVID-19.
Cozaar, MK 954, MK-954, DuP-753
Product should be kept at -20°C.
Goa, K. L., & Wagstaff, A. J. (1996). Losartan potassium. Drugs, 51(5), 820-845.
Sica, D. A., Gehr, T. W., & Ghosh, S. (2005). Clinical pharmacokinetics of losartan. Clinical pharmacokinetics, 44(8), 797-814.
Zeinalian, M., Salari-Jazi, A., Jannesari, A., & Khanahmad, H. (2020). A potential protective role of losartan against coronavirus-induced lung damage. Infection Control & Hospital Epidemiology, 1-2.